Global Cannabis Market - Strategic Insights and Forecasts (2026-2031)

The Global Cannabis Market is forecast to grow at a robust CAGR of 17.5%, significantly expanding its valuation. The market is projected to reach USD 171.1 billion in 2031, up from USD 76.5 billion in 2026, driven by ongoing structural transformations and increasing regulatory formalization across regions.

Key regulatory shifts, such as the U.S. executive branch's directive to reschedule cannabis and Germany's Cannabis Act (CanG) establishing a dual framework, are shaping the market. Asia-Pacific, exemplified by Thailand's medical-first approach with mandatory GACP compliance, further highlights a global reorientation towards standardized and regulated cannabis frameworks.

The market is undergoing a structural transformation into a multi-layered industry spanning medical use, regulated adult-use frameworks, pharmaceutical cannabinoids, and industrial hemp derivatives. Notably, pharmaceutical integration of cannabinoid-based prescription medicines, including CBD formulations, represents a distinct segment with stringent manufacturing and clinical oversight requirements.

By 2031, the market environment is expected to heavily favor entities capable of meeting pharmaceutical-grade production standards, navigating multi-jurisdictional compliance, and maintaining controlled supply chains. The industry is increasingly aligning with healthcare, pharmaceutical, and regulated consumer goods frameworks rather than traditional agricultural models, prioritizing product quality, traceability, and safety.

Regulatory clarity has become the defining factor for market participation, creating a professionalized supply chain. Companies capable of meeting standardized cultivation, manufacturing, and distribution requirements will increasingly differentiate themselves, favoring compliant operators over informal or legacy producers in a multi-layered market.

The market's expansion is primarily supported by the gradual liberalization of cannabis regulations for medical and controlled adult use across multiple regions. This legislative reform, coupled with a growing emphasis on product quality, traceability, and patient or consumer safety, underpins the market's robust growth trajectory.